BRIEF published on 10/23/2026 at 07:05, 17 days 20 hours ago BB Biotech AG Reports Strong Interim Financial Results Biotechnology Investment Company Net Profit BB Biotech AG Interim Report
BRIEF published on 10/23/2026 at 07:05, 17 days 20 hours ago BB Biotech's Q3 2026: Gains and Strategic Portfolio Moves AI Integration Net Profit BB Biotech Q3 2026 Drug Approvals
PRESS RELEASE published on 10/23/2026 at 07:00, 17 days 20 hours ago EQS-Adhoc: BB Biotech AG publishes its interim report BB Biotech AG publishes interim report for the first nine months of 2026, reporting a net profit of CHF 605 mn. Third quarter profit at CHF 175 mn Investment Company Q3 Results Net Profit BB Biotech AG Interim Report
PRESS RELEASE published on 10/23/2026 at 07:00, 17 days 20 hours ago BB Biotech Q3 2026: Positive returns, clinical progress and active portfolio redeployment BB Biotech AG reports positive returns, clinical progress, and active portfolio redeployment in Q3 2026, with a 5.6% NAV return and 6.5% share price return in CHF BB Biotech AG Returns Clinical Progress Q3 2026 Portfolio Redeployment
BRIEF published on 07/28/2026 at 15:25, 3 months 12 days ago Edison Research Analyzes BB Biotech's Robust Q2 Performance Investment Strategy Portfolio Expansion Market Outlook BB Biotech Q2 2026 Results
PRESS RELEASE published on 07/28/2026 at 15:20, 3 months 12 days ago Edison issues report on BB Biotech (BION) Edison issues favorable report on BB Biotech (BION) Q226 results, highlighting NAV growth, portfolio adjustments, and revised payout policy, supporting positive outlook for biotechnology investing Biotechnology Edison Report BB Biotech Q226 Results
BRIEF published on 07/24/2026 at 07:05, 3 months 16 days ago BB Biotech AG Reports Interim Gains and Adjusts Dividend Policy Dividend Policy Investment Portfolio Interim Report BB Biotech Net Gain
BRIEF published on 07/24/2026 at 07:05, 3 months 16 days ago BB Biotech Q2 2026: Robust NAV Performance Amid Strategic Investments Portfolio Diversification Dividend Policy Strategic Investments M&A Activity Biotechnology Performance
PRESS RELEASE published on 07/24/2026 at 07:00, 3 months 16 days ago EQS-Adhoc: BB Biotech AG publishes its interim report and revises its dividend policy BB Biotech AG publishes its interim report for the first half of 2026, reporting a net gain and revising its dividend policy. Details at www.bbbiotech.ch Financial Results Investment Company Dividend Policy BB Biotech AG Interim Report
PRESS RELEASE published on 07/24/2026 at 07:00, 3 months 16 days ago BB Biotech Q2 2026: Strong NAV outperformance driven by disciplined stock selection and portfolio positioning BB Biotech AG reports strong NAV outperformance in Q2 2026, driven by disciplined stock selection and portfolio positioning, new investments, and revised dividend policy Dividend Policy BB Biotech AG Stock Selection Q2 2026 NAV Outperformance
Published on 11/09/2026 at 23:10, 4 hours 37 minutes ago Ur-Energy Reports Third Quarter 2026 Results
Published on 11/09/2026 at 23:00, 4 hours 47 minutes ago LNG Energy Group Announces Issuance of Third Partial Revocation Order and Proposed Shares-for-Debt Settlement
Published on 11/09/2026 at 22:32, 5 hours 15 minutes ago Announces Extension for Closing of Private Placement of Convertible Promissory Notes
Published on 11/09/2026 at 22:15, 5 hours 32 minutes ago Goldcliff Announces Closing of the Second and Final Tranche of its "LIFE" Offering and Completion of Drilling at Kettle Valley
Published on 11/10/2026 at 01:20, 2 hours 26 minutes ago US defence customer steps up orders and first graphene oxide orders secured
Published on 11/09/2026 at 22:54, 4 hours 52 minutes ago EQS-Adhoc: Northern Data Group reports Q3 2026 and raises its FY 2026 revenue outlook communicated on 17 June 2026
Published on 11/09/2026 at 22:10, 5 hours 36 minutes ago Quantinuum to Participate in the Cantor Convergence 4th Annual Crypto, FinTech, AI & Energy Infrastructure Conference
Published on 11/09/2026 at 22:05, 5 hours 42 minutes ago Mayr-Melnhof Karton AG: MM Group to sell majority stake in its Packaging business to KPS Capital Partners and plans a special distribution to shareholders
Published on 11/09/2026 at 18:30, 9 hours 17 minutes ago Air Liquide has successfully issued a CHF 390 million multi-tranche bond
Published on 11/09/2026 at 17:35, 10 hours 12 minutes ago Disclosure of transactions in own shares from November 2 to November 6, 2026
Published on 11/09/2026 at 10:32, 17 hours 15 minutes ago Disclosure of shares outstanding and voting rights - 09.11.2026
Published on 11/09/2026 at 07:00, 20 hours 47 minutes ago bioMérieux receives U.S. FDA 510(k) clearance for the latest versions of the BIOFIRE® FILMARRAY® Gastrointestinal Panels to enhance detection of gastrointestinal pathogens including norovirus
